Manning, Paul M.
Hamilton, Gavin
Wang, Kang
Park, Chulhyun
Hooker, Jonathan C.
Wolfson, Tanya
Gamst, Anthony
Haufe, William M.
Schlein, Alex N.
Middleton, Michael S.
Sirlin, Claude B.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088925)
National Institutes of Health (TL1TR00098)
Article History
First Online: 29 September 2016
Compliance with ethical standards
:
: This study was partially supported by the National Institutes of Health, Grants R01DK088925, and TL1TR00098.
: Paul M. Manning, Gavin Hamilton, Kang Wang, Chulhyun Park, Jonathan C. Hooker, Tanya Wolfson, Anthony Gamst, William M. Haufe, Alex N. Schlein, and Michael S. Middleton declare that they have no conflict of interest. Claude B. Sirlin is a consultant to Bayer Healthcare and a member of an advisory board for Bayer Healthcare. He has also received research grants from Siemens and GE.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.